Abbott has reduced its 2026 guidance after saying the Exact deal will weigh on results, according to Investing.com (www.investing.com) in the article at https://www.investing.com/news/stock-market-news/abbott-results-beat-on-medical-device-boost-exact-deal-hits-forecast-4617849. The source says the piece was originally published on 2026-04-16 at 18:20:34+02:00.
For active traders, this matters because guidance changes often drive near-term price action more than the reported numbers themselves. A lower outlook can reset expectations, pressure sentiment, and keep the stock sensitive to follow-through in healthcare and medical-device names. In this case, the headline points to a mixed setup: results beat estimates, but the forward view was cut, which is typically what the market focuses on first.